Cleared Special

K243892 - Affera Integrated Mapping System

K243892 is the FDA 510(k) clearance for Affera Integrated Mapping System by Medtronic, Inc.. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Special 510(k) pathway after a 30-day FDA review.

K243892 · Medtronic, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2025
Decision
30d
Days
Class 2
Risk

K243892 is an FDA 510(k) clearance for the Affera Integrated Mapping System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on January 17, 2025 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medtronic, Inc. devices

Submission Details

510(k) Number K243892 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 18, 2024
Decision Date January 17, 2025
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 246
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K243892.
VitalRhythm
K242129 · Vitalconnect, Inc. · Apr 2025
Intra-Operative Positioning System (IOPS®)
K243842 · Centerline Biomedical, Inc. · Mar 2025
CER-S
K243312 · Cardiocalm Srl · Feb 2025
Mac-Lab (AltiX AI.i)
K243540 · Ge Medical Systems Information Technologies, Inc. · Dec 2024
Magnetic Localization Patch Kit (AFR-00021)
K243435 · Medtronic, Inc. · Dec 2024
DeepRhythmAI
K241197 · Medicalgorithmics S.A. · Dec 2024